Skip to main content
OpenTrials

Clinical trial condition

Diabetes Mellitus, Type 1

Explore clinical trials studying Diabetes Mellitus, Type 1. Study availability and eligibility vary by location and protocol.

2,900 public trials 332 recruiting studies
Refine in advanced search Browse all conditions

Diabetes Mellitus, Type 1 trial results

Recruiting

Clinical Study to Evaluate the Impact of the Accu-Chek SmartGuide CGM Solution on the Mean Change in Time in Range Compared With Self-Monitoring of Blood Glucose in Participants With Type 1 and Type 2 Diabetes Mellitus

NCT06704672

Conditions
Autoimmune Diseases, Diabetes Mellitus, Diabetes Mellitus, Type 1, +8 more
Locations
  • Centrum Badań Klinicznych PI-House sp. z o.o. Gdansk, Poland
  • Diabetes Technology Center, Jagiellonian University Medical College Krakow, Poland
  • NZOZ Neuromed Kraśnik, Poland
  • NZOZ Neuromed Lublin, Poland
View all 19 locations
View Trial Details
Recruiting

Safety Evaluation of MODI, an Insulin Titration Algorithm, in Adults With Diabetes

NCT07599982

Conditions
Autoimmune Diseases, Diabetes Mellitus, Diabetes Mellitus, Type 1, +10 more
Locations
  • Henry Ford Health System Detroit, Michigan, United States
  • SUNY Upstate Medical Center Albany, New York, United States
  • Texas Diabetes & Endocrinology Austin, Texas, United States
  • Diabetes & Endocrine Treatment Specialisits (DETS) Sandy City, Utah, United States
View Trial Details
Recruiting

HLA Demographics Study in Adults With Type 1 Diabetes

NCT06860516

Conditions
Autoimmune Diseases, Diabetes Mellitus, Diabetes Mellitus, Type 1, +6 more
Locations
  • University of California, San Francisco San Francisco, California, United States
  • University of Florida- Gainesville Gainesville, Florida, United States
  • Joslin Diabetes Center Boston, Massachusetts, United States
  • Icahn School of Medicine at Mount Sinai New York, United States
View Trial Details
Recruiting

General Use-results Surveillance With Awiqli in Patients With Diabetes Mellitus

NCT06807190

Conditions
Autoimmune Diseases, Diabetes Mellitus, Diabetes Mellitus, Type 1, +5 more
Locations
  • Seino Internal Medicine Clinic_Internal medicine Koriyama-shi, Fukushima, Fukushima, Japan, Japan
  • Abe Diabetes Clinic_Internal Medicine Oita-shi, Oita,, Japan
  • Jinnouchi Hospital_Internal Medicine Kumamoto, Kumamoto, Japan, Japan
  • Miyachi Clinic Aichi, Japan
View all 116 locations
View Trial Details
Recruiting

Family Intervention for Black Teens With Type 1 Diabetes

NCT06275412

Conditions
Autoimmune Diseases, Diabetes Mellitus, Diabetes Mellitus, Type 1, +7 more
Locations
  • Children's National Hospital Washington D.C., District of Columbia, United States
  • Wayne Pediatrics Detroit, Michigan, United States
  • LeBonheur Children's Hospital Memphis, Tennessee, United States
  • University of Tennessee Health Science Center-Memphis Memphis, Tennessee, United States
View Trial Details
Recruiting

Real-World Study of Patients With Type 1 Diabetes Treated With Teplizumab as Part of Managed Access Programs (MAPs)

NCT07457580

Conditions
Autoimmune Diseases, Diabetes Mellitus, Diabetes Mellitus, Type 1, +6 more
Locations
  • Investigational Site Number: 0560001 Leuven, Belgium
  • Investigational Site Number: 2500001 Bron, France
  • Investigational Site Number: 2500003 Paris, France
  • Investigational Site Number: 2500002 Paris, France
View all 14 locations
View Trial Details
Recruiting

Long-Term Outcomes of Teplizumab in Routine Clinical Care

NCT07360080

Conditions
Autoimmune Diseases, Diabetes Mellitus, Diabetes Mellitus, Type 1, +6 more
Locations
  • Investigational Site Number: 8400003 Atlanta, Georgia, United States
  • Investigational Site Number: 8400005 Sandy City, Utah, United States
  • Investigational Site Number: 3760001 Ramat Gan, Israel
  • Investigational Site Number: 8400004 Atlanta, Georgia, United States
View Trial Details

Related conditions